Skip to content

Clinical efficacy and Therapeutic Mechanism of Yiqihuoxuetongqiaomingmu recipe in the treatment of non-Arterial Ischemic Optic Neuropathy (NAION)

Clinical efficacy and Therapeutic Mechanism of Yiqihuoxuetongqiaomingmu recipe in the treatment of non-Arterial Ischemic Optic Neuropathy (NAION)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027689
Enrollment
Unknown
Registered
2019-11-23
Start date
2019-11-20
Completion date
Unknown
Last updated
2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-Arterial Ischemic Optic Neuropathy

Interventions

Sponsors

the first affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. In accordance with the diagnostic criteria of "expert consensus on diagnosis and treatment of non-arteritis Ischemic Optic Neuropathy in China (2015)"; 2. Aged 18 to 70 years old; 3. the syndrome differentiation of traditional Chinese medicine accords with the syndrome of qi deficiency and blood stasis: The main syndrome: (1) the visual object is faint; (2) the visual object is occluded; Concurrently syndrome 1: (1) the complexion was pale or dark; (2) Palpitations, shortness of breath and forgetfulness; (3) Tired, yellowed, tired and lazy; (4) The quality of the tongue is light Concurrently syndrome 2: (1) headache or eye pain, pain such as a thorn, pain fixed; (2) Ecchymosis of tongue; (3) the pulse is thin or weak Has at least one of the main symptoms, and has at least one of the concurrently syndrome 1 and 2 respectively.

Exclusion criteria

Exclusion criteria: (1) complicated with other ophthalmopathy and temporal artery inflammatory lesions affecting visual function; (2) absence of light sensation more than 7 degree, course of disease more than 3 months; (3) excluding other optic nerve diseases that can cause optic disc edema and visual impairment, such as glaucoma, optic neuritis, optic nerve atrophy and so on; (4) allergic to drugs (including methylprednisolone sodium succinate, methylprednisolone tablets, vitamin B1, mecobalamin tablets, traditional Chinese medicine granules); (5) pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
best corrected visual acuity;mean visual field defect;

Secondary

MeasureTime frame
pattern visual evoked potential;optical coherence tomography;fundus fluorescein angiography;score of Syndrome scale of traditional Chinese Medicine;

Countries

China

Contacts

Public ContactNi TIAN

the First Clinical Medical College of Guangzhou University of Chinese Medicine

tianni213@126.com+86 15360533872

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026